Skip to main content
SpringerLink
Log in

Myeloproliferative Disorders

  • Book
  • © 2007

Overview

Authors:
  1. Junia V. Melo

    1. Department of Haematology, Faculty of Medicine, Imperial College London, Hammersmith Hospital, London, UK

    View author publications

    You can also search for this author in PubMed   Google Scholar

  2. John M. Goldman

    1. Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, USA

    View author publications

    You can also search for this author in PubMed   Google Scholar

  • Very up-to-date book in this rapidly moving field
  • Written by internationally renowned academics
  • Ph-positive chronic myeloid leukemia are also included like the ph-negative variants
  • Insights into the molecular mechanisms of the leukemias
  • Includes supplementary material: sn.pub/extras

Part of the book series: Hematologic Malignancies (HEMATOLOGIC)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (18 chapters)

  1. Front Matter

    Pages I-XI
    Download chapter PDF

  2. Chronic Myeloid Leukemia — A Brief History

    • John M. Goldman, George Q. Daley
    Pages 1-13

  3. Bcr-Abl and Signal Transduction

    • Daniela Cilloni, Giuseppe Saglio
    Pages 15-35

  4. Chronic Myeloid Leukemia: Biology of Advanced Phase

    • Junia V. Melo, David J. Barnes
    Pages 37-58

  5. Clinical Features of CML

    • Mira Farquharson, Pat Shepherd
    Pages 59-74

  6. Signal Transduction Inhibitors in Chronic Myeloid Leukemia

    • Michael W. N. Deininger
    Pages 75-102

  7. Treatment with Tyrosine Kinase Inhibitors

    • Andreas Hochhaus
    Pages 103-113

  8. Allogeneic Transplantation for CML

    • Charles Crawley, Jerald Radich, Jane Apperley
    Pages 115-131

  9. Autografting in Chronic Myeloid Leukemia

    • Eduardo Olavarria
    Pages 133-141

  10. Monitoring Disease Response

    • Timothy Hughes, Susan Branford
    Pages 143-164

  11. New Therapies for Chronic Myeloid Leukemia

    • Alfonso Quintás-Cardama, Hagop Kantarjian, Jorge Cortes
    Pages 165-184

  12. Immune Therapy of Chronic Myelogenous Leukemia

    • Axel Hoos, Robert Peter Gale
    Pages 185-200

  13. Therapeutic Strategies and Concepts of Cure in CML

    • Tariq I Mughal, John M Goldman
    Pages 201-218

  14. BCR-ABL-Negative Chronic Myeloid Leukemia

    • Nicholas C. P. Cross, Andreas Reiter
    Pages 219-233

  15. Hypereosinophilic Syndrome

    • Elizabeth H. Stover, Jason Gotlib, Jan Cools, D. Gary Gilliland
    Pages 235-251

  16. Chronic Idiopathic Myelofibrosis

    • John T. Reilly
    Pages 253-276

  17. Polycythemia Vera — Clinical Aspects

    • Alison R. Moliterno, Jerry L. Spivak
    Pages 277-296

  18. Polycythemia Vera and Other Polycythemic Disorders — Biological Aspects

    • Sonny O. Ang, Josef T. Prchal
    Pages 297-319

  19. Essential Thrombocythemia

    • Ayalew Tefferi
    Pages 321-348

  20. Back Matter

    Pages 349-354
    Download chapter PDF
Back to top

Keywords

Reviews

From the reviews:

"... a superb summary of the topic, is a modern synthesis of Dameshek’s adventurous thinking. ... Myeloproliferative Disorders is an important contribution to hematology. It arrives at a time when the study and treatment of these important diseases is at a crossroads, a time when hematologists everywhere have come to expect that the next great leap forward will come soon. For me, this book will sit on the shelf next to the first edition of Dameshek’s Leukemia. ..." (Robert Schwartz, New England Journal of Medicine, 356/ 24, June 2007)

"First identified and named by William Dameshek in 1951, myeloproliferative disorders have become ‘landmarks in the history of malignant disease … on which progress in understanding and treating other malignancies … and indeed solid tumors can be based.’ … it ‘should be of interest to medical students who find the specialty of hematology truly fascinating.’ For other physicians and for patients, this reference provides a needed understanding of avant-garde medical research." (William H. Wehrmacher, JAMA, Vol. 298, 2007)

Authors and Affiliations

  • Department of Haematology, Faculty of Medicine, Imperial College London, Hammersmith Hospital, London, UK

    Junia V. Melo

  • Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, USA

    John M. Goldman

Bibliographic Information

  • Book Title: Myeloproliferative Disorders

  • Authors: Junia V. Melo, John M. Goldman

  • Series Title: Hematologic Malignancies

  • DOI: https://doi.org/10.1007/978-3-540-34506-0

  • Publisher: Springer Berlin, Heidelberg

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer-Verlag Berlin Heidelberg 2007

  • Hardcover ISBN: 978-3-540-34505-3Published: 27 November 2006

  • Softcover ISBN: 978-3-642-42112-9Published: 13 December 2014

  • eBook ISBN: 978-3-540-34506-0Published: 06 March 2007

  • Series ISSN: 2197-9766

  • Series E-ISSN: 2197-9774

  • Edition Number: 1

  • Number of Pages: XI, 354

  • Topics: Hematology, Oncology

Publish with us

Policies and ethics

Back to top

Search

Navigation